Epigenetic Modifications in Prostate Cancer Metastasis and Microenvironment

被引:6
作者
Zhang, Shouyi [1 ,2 ]
Shen, Tao [3 ]
Zeng, Yu [1 ,2 ]
机构
[1] Dalian Univ Technol, Dept Urol, Canc Hosp, Shenyang 110042, Peoples R China
[2] Liaoning Canc Hosp, Shenyang 110042, Peoples R China
[3] Shenyang Med Coll, Dept Urol, Affiliated Hosp 2, 20 Beijiu Rd, Shenyang 110001, Peoples R China
基金
中国国家自然科学基金;
关键词
epigenetic modifications; prostate cancer; tumor microenvironment; tumor remodeling; ANDROGEN-RECEPTOR; DNA METHYLATION; MESENCHYMAL TRANSITION; MESSENGER-RNA; PROTEIN RBM3; EXPRESSION; CELLS; M(6)A; GENE; PROLIFERATION;
D O I
10.3390/cancers15082243
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Epigenetics, which leads to specific differentiation events and determines gene expression states, has been recognized as a developmental landscape. Epigenetic modifications are widespread in mammals. Dysregulation of epigenetic modifications is closely related to the occurrence of diseases, especially cancer. The relationship between epigenetic modification and cancer has been widely studied. This review aims to summarize the different epigenetic modifications events that occur in prostate cancer and improve our understanding of the biological role of epigenetic modifications in prostate cancer metastasis. The gradual evolution of prostate tissue from benign tumor to malignant lesion or distant metastasis is driven by intracellular epigenetic changes and the tumor microenvironment remodeling. With the continuous study of epigenetic modifications, these tumor-driving forces are being discovered and are providing new treatments for cancer. Here we introduce the classification of epigenetic modification and highlight the role of epigenetic modification in tumor remodeling and communication of the tumor microenvironment.
引用
收藏
页数:16
相关论文
共 136 条
  • [1] CRISPRi screens reveal a DNA methylation-mediated 3D genome dependent causal mechanism in prostate cancer
    Ahmed, Musaddeque
    Soares, Fraser
    Xia, Ji-Han
    Yang, Yue
    Li, Jing
    Guo, Haiyang
    Su, Peiran
    Tian, Yijun
    Lee, Hyung Joo
    Wang, Miranda
    Akhtar, Nayeema
    Houlahan, Kathleen E.
    Bosch, Almudena
    Zhou, Stanley
    Mazrooei, Parisa
    Hua, Junjie T.
    Chen, Sujun
    Petricca, Jessica
    Zeng, Yong
    Davies, Alastair
    Fraser, Michael
    Quigley, David A.
    Feng, Felix Y.
    Boutros, Paul C.
    Lupien, Mathieu
    Zoubeidi, Amina
    Wang, Liang
    Walsh, Martin J.
    Wang, Ting
    Ren, Shancheng
    Wei, Gong-Hong
    He, Housheng Hansen
    [J]. NATURE COMMUNICATIONS, 2021, 12 (01)
  • [2] N6-methyladenosine marks primary microRNAs for processing
    Alarcon, Claudio R.
    Lee, Hyeseung
    Goodarzi, Hani
    Halberg, Nils
    Tavazoie, Sohail F.
    [J]. NATURE, 2015, 519 (7544) : 482 - +
  • [3] Epigenetic regulation of CXCR4 signaling in cancer pathogenesis and progression
    Alsayed, Reem Khaled M. E.
    Khan, Abdul Q.
    Ahmad, Fareed
    Ansari, Abdul Wahid
    Alam, Majid Ali
    Buddenkotte, Jorg
    Steinhoff, Martin
    Uddin, Shahab
    Ahmad, Aamir
    [J]. SEMINARS IN CANCER BIOLOGY, 2022, 86 : 697 - 708
  • [4] A naturally occurring splice variant of CXCL12/stromal cell-derived factor 1 is a potent human immunodeficiency virus type 1 inhibitor with weak chemotaxis and cell survival activities
    Altenburg, Jeffrey D.
    Broxmeyer, Hal E.
    Jin, Qingwen
    Cooper, Scott
    Basu, Sunanda
    Alkhatib, Ghalib
    [J]. JOURNAL OF VIROLOGY, 2007, 81 (15) : 8140 - 8148
  • [5] Dynamic Nucleosome-Depleted Regions at Androgen Receptor Enhancers in the Absence of Ligand in Prostate Cancer Cells
    Andreu-Vieyra, Claudia
    Lai, John
    Berman, Benjamin P.
    Frenkel, Baruch
    Jia, Li
    Jones, Peter A.
    Coetzee, Gerhard A.
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2011, 31 (23) : 4648 - 4662
  • [6] Acetylation of Cytidine in mRNA Promotes Translation Efficiency
    Arango, Daniel
    Sturgill, David
    Alhusaini, Najwa
    Dillman, Allissa A.
    Sweet, Thomas J.
    Hanson, Gavin
    Hosogane, Masaki
    Sinclair, Wilson R.
    Nanan, Kyster K.
    Mandler, Mariana D.
    Fox, Stephen D.
    Zengeya, Thomas T.
    Andresson, Thorkell
    Meier, Jordan L.
    Coller, Jeffery
    Oberdoerffer, Shalini
    [J]. CELL, 2018, 175 (07) : 1872 - +
  • [7] Prostate cancer
    Attard, Gerhardt
    Parker, Chris
    Eeles, Ros A.
    Schroder, Fritz
    Tomlins, Scott A.
    Tannock, Ian
    Drake, Charles G.
    de Bono, Johann S.
    [J]. LANCET, 2016, 387 (10013) : 70 - 82
  • [8] Epigenetic Drugs for Cancer and microRNAs: A Focus on Histone Deacetylase Inhibitors
    Autin, Pierre
    Blanquart, Christophe
    Fradin, Delphine
    [J]. CANCERS, 2019, 11 (10)
  • [9] WNT signaling in bone homeostasis and disease: from human mutations to treatments
    Baron, Roland
    Kneissel, Michaela
    [J]. NATURE MEDICINE, 2013, 19 (02) : 179 - 192
  • [10] Global Levels of Specific Histone Modifications and an Epigenetic Gene Signature Predict Prostate Cancer Progression and Development
    Bianco-Miotto, Tina
    Chiam, Karen
    Buchanan, Grant
    Jindal, Shalini
    Day, Tanya K.
    Thomas, Mervyn
    Pickering, Marie A.
    O'Loughlin, Melissa A.
    Ryan, Natalie K.
    Raymond, Wendy A.
    Horvath, Lisa G.
    Kench, James G.
    Stricker, Phillip D.
    Marshall, Villis R.
    Sutherland, Robert L.
    Henshall, Susan M.
    Gerald, William L.
    Scher, Howard I.
    Risbridger, Gail P.
    Clements, Judith A.
    Butler, Lisa M.
    Tilley, Wayne D.
    Horsfall, David J.
    Ricciardelli, Carmela
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2010, 19 (10) : 2611 - 2622